2014Shanghai Journal of Traditional Chinese MedicineRequires access

Clinical observation of “Hekun Decoction” for perimenopausal syndrome

S Zhang

Open publisher page 0 citations

Abstract

Objective This study is to observe the clinical efficacy of Hekun Decoction on perimenopausal syndrome. Methods Sixty patients with perimenopausal syndrome were randomized in treatment group and control group,with 30 cases in each group. The patients in treatment group were givenHekun Decoction,and the patients in control group were given Tibolone tablets or Kelimen tablets. Two groups were treated for three months. The clinical efficacy and the changes of clinical syndrome score were observed. Results The total effective rate of treatment group was 86. 7 % and that of control group was 90 %,with no significant difference between the two groups( P 0. 05); after the treatment,clinical syndrome score were significantly reduced in both of two groups( P 0. 01),with no significant difference between the groups( P 0. 05). ConclusionHekun Decoctionmay treat perimenopausal syndrome effectively,equally as hormone therapy does.

About this research paper

What this paper is about

Objective This study is to observe the clinical efficacy of Hekun Decoction on perimenopausal syndrome. Methods Sixty patients with perimenopausal syndrome were randomized in treatment group and control group,with 30 cases in each group. The patients in treatment group were givenHekun Decoction,and the patients in control group were given Tibolone tablets or Kelimen tablets. Two groups were treated for three months. The clinical efficacy and the changes of clinical syndrome score were observed. Results The total effective rate of treatment group was 86. 7 % and that of control group was 90 %,with no significant difference between the two groups( P 0. 05); after the treatment,clinical syndrome score were significantly reduced in both of two groups( P 0. 01),with no significant difference between the groups( P 0. 05). ConclusionHekun Decoctionmay treat perimenopausal syndrome effectively,equally as hormone therapy does.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective This study is to observe the clinical efficacy of Hekun Decoction on perimenopausal syndrome. Methods Sixty patients with perimenopausal syndrome were randomized in treatment group and control group,with 30 cases in each group. The patients in treatment group were givenHekun Decoction,and the patients in control group were given Tibolone tablets or Kelimen tablets. Two groups were treated for three months. The clinical efficacy and the changes of clinical syndrome score were observed. Results The total effective rate of treatment group was 86. 7 % and that of control group was 90 %,with no significant difference between the two groups( P 0. 05); after the treatment,clinical syndrome score were significantly reduced in both of two groups( P 0. 01),with no significant difference between the groups( P 0. 05). ConclusionHekun Decoctionmay treat perimenopausal syndrome effectively,equally as hormone therapy does.

Key concepts: Medicine, Decoction, Tibolone, Clinical efficacy, Internal medicine, Treatment and control groups, Significant difference, Menopause

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical observation of “Hekun Decoction” for perimenopausal syndrome — Research Paper | ScholarLens